Literature DB >> 10229397

Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells.

Y Kumon1, T Suehiro, K Hashimoto, K Nakatani, J D Sipe.   

Abstract

OBJECTIVE: Serum amyloid A (SAA) protein, a bioactive protein produced during inflammation, is present in synovial fluid (SF) of patients with rheumatoid arthritis (RA). Based on our recent finding that SF SAA concentration exceeded the serum counterpart in some patients with RA, we examined the local steady state concentration of SAA mRNA isoforms in synovia and in synovial cells cultured from patients with RA and osteoarthritis (OA).
METHODS: Total cellular RNA from synovial membranes of patients with RA or OA and from cultured synovial cells of patients with RA was analyzed by reverse transcription polymerase chain reaction and Northern blot.
RESULTS: Acute phase SAA (A-SAA) mRNA isoforms were detected only in RA synovia, but not in OA synovia; however, the constitutive SAA (C-SAA) mRNA isoform was detected in similar abundance in both OA and RA synovia. There was evidence of C-SAA, but not A-SAA mRNA in cultured synovial cells at quiescence. After stimulation with both 1 mM dexamethasone and 10 ng/ml interleukin 1beta (IL-1beta), the quantity of steady state A-SAA muRNA in cultured synovial cells was markedly increased.
CONCLUSION: Both A-SAA and C-SAA mRNA are detectable in RA synovia, while only C-SAA mRNA is detectable in OA and in quiescent cultured synovial cells. The steady state A-SAA mRNA isoform in cultured synovial cells was markedly increased in the presence of dexamethasone plus IL-1beta. The local synthesis of A-SAA may contribute, at least in part, to the concentration of A-SAA protein in SF and may contribute to the altered molecular and cellular physiology in RA joints.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229397

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  18 in total

1.  Chronic oral infection with major periodontal bacteria Tannerella forsythia modulates systemic atherosclerosis risk factors and inflammatory markers.

Authors:  Sasanka S Chukkapalli; Mercedes F Rivera-Kweh; Irina M Velsko; Hao Chen; Donghang Zheng; Indraneel Bhattacharyya; Pandu R Gangula; Alexandra R Lucas; Lakshmyya Kesavalu
Journal:  Pathog Dis       Date:  2015-02-05       Impact factor: 3.166

2.  The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice.

Authors:  Christine H J Kim; James B Mitchell; Christina A Bursill; Anastasia L Sowers; Angela Thetford; John A Cook; David M van Reyk; Michael J Davies
Journal:  Atherosclerosis       Date:  2015-03-16       Impact factor: 5.162

3.  Induction of interleukin-23 p19 by serum amyloid A (SAA) in rheumatoid synoviocytes.

Authors:  K Migita; T Koga; T Torigoshi; S Motokawa; Y Maeda; Y Jiuchi; Y Izumi; T Miyashita; M Nakamura; A Komori; H Ishibashi
Journal:  Clin Exp Immunol       Date:  2010-09-14       Impact factor: 4.330

4.  Effect of serum amyloid A1 treatment on global gene expression in THP-1-derived macrophages.

Authors:  Koon-Yeow Leow; Wilson Wen Bin Goh; Chew-Kiat Heng
Journal:  Inflamm Res       Date:  2012-01-08       Impact factor: 4.575

5.  Expression of serum amyloid a in human ovarian epithelial tumors: implication for a role in ovarian tumorigenesis.

Authors:  Simcha Urieli-Shoval; Zvezdana Finci-Yeheskel; Shira Dishon; Daliah Galinsky; Reinhold P Linke; Ilana Ariel; Mark Levin; Inbar Ben-Shachar; Diana Prus
Journal:  J Histochem Cytochem       Date:  2010-08-16       Impact factor: 2.479

6.  Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2.

Authors:  Rong L He; Jian Zhou; Crystal Z Hanson; Jia Chen; Ni Cheng; Richard D Ye
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

7.  Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A.

Authors:  Ni Cheng; Rong He; Jun Tian; Patrick P Ye; Richard D Ye
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells.

Authors:  Irina N Baranova; Alexander V Bocharov; Tatyana G Vishnyakova; Roger Kurlander; Zhigang Chen; Dong Fu; Irwin M Arias; Gyorgy Csako; Amy P Patterson; Thomas L Eggerman
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

9.  Native and oxidised lipoproteins negatively regulate the serum amyloid A-induced NLRP3 inflammasome activation in human macrophages.

Authors:  Katariina Nurmi; Katri Niemi; Ilona Kareinen; Kristiina Silventoinen; Martina B Lorey; Yan Chen; Vesa-Petteri Kouri; Jukka Parantainen; Timo Juutilainen; Katariina Öörni; Petri T Kovanen; Dan Nordström; Sampsa Matikainen; Kari K Eklund
Journal:  Clin Transl Immunology       Date:  2021-08-03

10.  Polymicrobial infection with major periodontal pathogens induced periodontal disease and aortic atherosclerosis in hyperlipidemic ApoE(null) mice.

Authors:  Mercedes F Rivera; Ju-Youn Lee; Monika Aneja; Vishalkant Goswami; Liying Liu; Irina M Velsko; Sasanka S Chukkapalli; Indraneel Bhattacharyya; Hao Chen; Alexandra R Lucas; Lakshmyya N Kesavalu
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.